Interferon beta-1a & beta-1b have antiviral and immunomodulating activities; mainly used in the management of multiple sclerosis

Indications: interferon beta–1a is used in relapsing remitting multiple sclerosis whereas interferon beta-1b is used in both relapsing – remitting and in secondary progressive multiple sclerosis.

Contra-indications: consult product/specialist literature

Side effect: The most frequently reported side effects include irritation at injection site (inflammation, hypersensitivity and necrosis), influenza-like symptoms, nausea, and vomiting. Other side effects include hypersensitivity reactions (anaphylaxis and urticaria), blood disorders, menstrual disorders, mood and convulsions, alopecia, hepatitis, and thyroid dysfunction.